Pemigatinib is this newFGFR blocker, mainly used for cholangiocarcinoma that has FGFR2 fusions. It stops that FGFR signaling that’s key for cancer growth and spreading. You got three dosages to choose from: 4.5 mg, 9 mg, and 13.5 mg.
The plan is to take one 13.5 mg pill every day for 14 days straight, then take a week off. That wraps up one 21-day cycle. Each pack’s got 14 of those 13.5 mg pills.
Reviews
There are no reviews yet.